Quince Therapeutics Receives Nasdaq Noncompliance Notice, Gets Time Through Oct. 15 To Regain Compliance
SEC.
Share
Why It Matters
Quince Therapeutics got a warning that it's not following Nasdaq's rules, but it has until mid-October to fix the problem. When a company gets warnings like this, it's a sign to watch if they can solve their issues quickly or if bigger problems might be hiding underneath.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.